Connection

Tommaso Lupia to Humans

This is a "connection" page, showing publications Tommaso Lupia has written about Humans.
Connection Strength

0.056
  1. Personalized stewardship and interdisciplinarity: key elements of COVID-19. Microbes Infect. 2021 Mar-Apr; 23(2-3):104781.
    View in: PubMed
    Score: 0.007
  2. Giardiasis reactivation during severe SARS-CoV-2 infection. Parasitol Int. 2021 02; 80:102241.
    View in: PubMed
    Score: 0.007
  3. COVID-19: in the uncertainty, do not try this at home. Intern Emerg Med. 2020 11; 15(8):1599-1600.
    View in: PubMed
    Score: 0.007
  4. Good times, bad times: A diary of a physician in the COVID-19 era. Eur J Intern Med. 2020 Jul; 77:132-133.
    View in: PubMed
    Score: 0.007
  5. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020 06; 21:22-27.
    View in: PubMed
    Score: 0.007
  6. A tinea immune reconstitution inflammatory syndrome in a HIV-positive patient starting combination antiretroviral treatment. G Ital Dermatol Venereol. 2020 Oct; 155(5):695-697.
    View in: PubMed
    Score: 0.006
  7. Antiviral treatment selection for SARS-CoV-2 pneumonia. Expert Rev Respir Med. 2021 08; 15(8):985-992.
    View in: PubMed
    Score: 0.002
  8. COVID-19 pneumonia: do not leave the corticosteroids behind! Future Microbiol. 2021 03; 16:317-322.
    View in: PubMed
    Score: 0.002
  9. Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury. Respir Physiol Neurobiol. 2021 06; 288:103645.
    View in: PubMed
    Score: 0.002
  10. COVID-19: where have the lymphocytes gone? Intern Med J. 2020 11; 50(11):1436-1437.
    View in: PubMed
    Score: 0.002
  11. Ozone therapy in COVID-19: A narrative review. Virus Res. 2021 01 02; 291:198207.
    View in: PubMed
    Score: 0.002
  12. Efficacy and safety of interferon-free regimens in patients affected by chronic hepatitis C and psychiatric disorders. J Infect Chemother. 2020 Jan; 26(1):18-22.
    View in: PubMed
    Score: 0.002
  13. Antiviral treatment with pegylated interferon and clinical outcomes in a cohort of immigrants patients affected by hepatitis delta: A retrospective analysis. J Med Virol. 2019 07; 91(7):1329-1334.
    View in: PubMed
    Score: 0.002
  14. Retreatment with sofosbuvir/velpatasvir in cirrhotic patients with genotype-4 who failed a previous interferon-free regimen: a case series. Antivir Ther. 2018; 23(6):543-547.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.